263 related articles for article (PubMed ID: 21282288)
1. The role of synaptobrevin1/VAMP1 in Ca2+-triggered neurotransmitter release at the mouse neuromuscular junction.
Liu Y; Sugiura Y; Lin W
J Physiol; 2011 Apr; 589(Pt 7):1603-18. PubMed ID: 21282288
[TBL] [Abstract][Full Text] [Related]
2. Ablation of All Synaptobrevin vSNAREs Blocks Evoked But Not Spontaneous Neurotransmitter Release at Neuromuscular Synapses.
Liu Y; Sugiura Y; Südhof TC; Lin W
J Neurosci; 2019 Jul; 39(31):6049-6066. PubMed ID: 31160536
[TBL] [Abstract][Full Text] [Related]
3. Rab3a deletion reduces vesicle docking and transmitter release at the mouse diaphragm synapse.
Coleman WL; Bill CA; Bykhovskaia M
Neuroscience; 2007 Aug; 148(1):1-6. PubMed ID: 17640821
[TBL] [Abstract][Full Text] [Related]
4. Synaptobrevin 1 mediates vesicle priming and evoked release in a subpopulation of hippocampal neurons.
Zimmermann J; Trimbuch T; Rosenmund C
J Neurophysiol; 2014 Sep; 112(6):1559-65. PubMed ID: 24944211
[TBL] [Abstract][Full Text] [Related]
5. Synaptotagmin-2 is essential for survival and contributes to Ca2+ triggering of neurotransmitter release in central and neuromuscular synapses.
Pang ZP; Melicoff E; Padgett D; Liu Y; Teich AF; Dickey BF; Lin W; Adachi R; Südhof TC
J Neurosci; 2006 Dec; 26(52):13493-504. PubMed ID: 17192432
[TBL] [Abstract][Full Text] [Related]
6. Rab3A deletion selectively reduces spontaneous neurotransmitter release at the mouse neuromuscular synapse.
Sons MS; Plomp JJ
Brain Res; 2006 May; 1089(1):126-34. PubMed ID: 16631140
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin-Synaptobrevin Fusion Protein Causes Degeneration of Presynaptic Motor Terminals in Mice.
Liu Y; Li H; Sugiura Y; Han W; Gallardo G; Khvotchev M; Zhang Y; Kavalali ET; Südhof TC; Lin W
J Neurosci; 2015 Aug; 35(33):11514-31. PubMed ID: 26290230
[TBL] [Abstract][Full Text] [Related]
8. BMP signaling modulates the probability of neurotransmitter release and readily releasable pools in Drosophila neuromuscular junction synapses.
Lee SH; Kim YJ; Choi SY
Biochem Biophys Res Commun; 2016 Oct; 479(3):440-446. PubMed ID: 27671198
[TBL] [Abstract][Full Text] [Related]
9. Gene dosage-dependent transmitter release changes at neuromuscular synapses of CACNA1A R192Q knockin mice are non-progressive and do not lead to morphological changes or muscle weakness.
Kaja S; van de Ven RC; Broos LA; Veldman H; van Dijk JG; Verschuuren JJ; Frants RR; Ferrari MD; van den Maagdenberg AM; Plomp JJ
Neuroscience; 2005; 135(1):81-95. PubMed ID: 16111830
[TBL] [Abstract][Full Text] [Related]
10. Increased neurotransmitter release at the neuromuscular junction in a mouse model of polyglutamine disease.
Rozas JL; Gómez-Sánchez L; Tomás-Zapico C; Lucas JJ; Fernández-Chacón R
J Neurosci; 2011 Jan; 31(3):1106-13. PubMed ID: 21248135
[TBL] [Abstract][Full Text] [Related]
11. Aberrant morphology and residual transmitter release at the Munc13-deficient mouse neuromuscular synapse.
Varoqueaux F; Sons MS; Plomp JJ; Brose N
Mol Cell Biol; 2005 Jul; 25(14):5973-84. PubMed ID: 15988013
[TBL] [Abstract][Full Text] [Related]
12. Members of the synaptobrevin/vesicle-associated membrane protein (VAMP) family in Drosophila are functionally interchangeable in vivo for neurotransmitter release and cell viability.
Bhattacharya S; Stewart BA; Niemeyer BA; Burgess RW; McCabe BD; Lin P; Boulianne G; O'Kane CJ; Schwarz TL
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13867-72. PubMed ID: 12364587
[TBL] [Abstract][Full Text] [Related]
13. Distinct requirements for evoked and spontaneous release of neurotransmitter are revealed by mutations in the Drosophila gene neuronal-synaptobrevin.
Deitcher DL; Ueda A; Stewart BA; Burgess RW; Kidokoro Y; Schwarz TL
J Neurosci; 1998 Mar; 18(6):2028-39. PubMed ID: 9482790
[TBL] [Abstract][Full Text] [Related]
14. Different VAMP/synaptobrevin complexes for spontaneous and evoked transmitter release at the crayfish neuromuscular junction.
Hua SY; Raciborska DA; Trimble WS; Charlton MP
J Neurophysiol; 1998 Dec; 80(6):3233-46. PubMed ID: 9862918
[TBL] [Abstract][Full Text] [Related]
15. Ceramidase regulates synaptic vesicle exocytosis and trafficking.
Rohrbough J; Rushton E; Palanker L; Woodruff E; Matthies HJ; Acharya U; Acharya JK; Broadie K
J Neurosci; 2004 Sep; 24(36):7789-803. PubMed ID: 15356190
[TBL] [Abstract][Full Text] [Related]
16. A role for solute carrier family 10 member 4, or vesicular aminergic-associated transporter, in structural remodelling and transmitter release at the mouse neuromuscular junction.
Patra K; Lyons DJ; Bauer P; Hilscher MM; Sharma S; Leão RN; Kullander K
Eur J Neurosci; 2015 Feb; 41(3):316-27. PubMed ID: 25410831
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity in synaptic vesicle release at neuromuscular synapses of mice expressing synaptopHluorin.
Wyatt RM; Balice-Gordon RJ
J Neurosci; 2008 Jan; 28(1):325-35. PubMed ID: 18171949
[TBL] [Abstract][Full Text] [Related]
18. Distribution of synaptobrevin/VAMP 1 and 2 in rat brain.
Raptis A; Torrejón-Escribano B; Gómez de Aranda I; Blasi J
J Chem Neuroanat; 2005 Dec; 30(4):201-11. PubMed ID: 16169186
[TBL] [Abstract][Full Text] [Related]
19. Morphological and functional effects of altered cysteine string protein at the Drosophila larval neuromuscular junction.
Dawson-Scully K; Lin Y; Imad M; Zhang J; Marin L; Horne JA; Meinertzhagen IA; Karunanithi S; Zinsmaier KE; Atwood HL
Synapse; 2007 Jan; 61(1):1-16. PubMed ID: 17068777
[TBL] [Abstract][Full Text] [Related]
20. AP180 maintains the distribution of synaptic and vesicle proteins in the nerve terminal and indirectly regulates the efficacy of Ca2+-triggered exocytosis.
Bao H; Daniels RW; MacLeod GT; Charlton MP; Atwood HL; Zhang B
J Neurophysiol; 2005 Sep; 94(3):1888-903. PubMed ID: 15888532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
